Ikena Oncology, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ikena Oncology, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • Ikena Oncology, Inc. Depreciation for the quarter ending March 31, 2024 was $219K, a 5.2% decline year-over-year.
  • Ikena Oncology, Inc. annual Depreciation for 2023 was $1.02M, a 35.8% increase from 2022.
  • Ikena Oncology, Inc. annual Depreciation for 2022 was $751K, a 38.1% increase from 2021.
  • Ikena Oncology, Inc. annual Depreciation for 2021 was $544K, a 81.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $219K -$12K -5.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $231K +$51K +28.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $635K $180K +$91K +102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $544K $255K +$229K +881% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $315K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $315K $100K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $315K $89K +$15K +20.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $300K $26K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $100K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $74K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.